Ziconotide acetate | CAS:107452-89-1

We serve Ziconotide acetate CAS:107452-89-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Ziconotide acetate

Chemical Name:Ziconotide acetate
CAS.NO:107452-89-1
Synonyms:Ziconotide acetate
Ziconotide
 
Physical and Chemical Properties:
Density 1.6±0.1 g/cm3
Molecular Formula C102H172N36O32S7
Molecular Weight 2639.134
Index of Refraction 1.710
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Ziconotide is used to treat severe chronic pain in people who cannot use or do not respond to standard pain-relieving medications.



Contact us for information like Ziconotide acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ziconotide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ziconotide Use and application,Ziconotide technical grade,usp/ep/jp grade.


Related News: The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China.2,4-dichloro-1-(dichloromethyl)benzene manufacturer We are pleased that he is doing well,” said BPHC Executive Director Rita Nieves. “Right now, we are not asking Boston residents to do anything differently.4-Bromoveratrole supplier We are pleased that he is doing well,” said BPHC Executive Director Rita Nieves. “Right now, we are not asking Boston residents to do anything differently.2-Fluoro-3-iodopyridine vendor Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.